ABT-594 [(R)-5-(2-azetidinylmethoxy)-2-chloropyridine]: a novel, orally effective antinociceptive agent acting via neuronal nicotinic acetylcholine receptors: II. In vivo characterization.

Autor: W, Bannon A, W, Decker M, P, Curzon, J, Buckley M, J, Kim D, J, Radek R, K, Lynch J, T, Wasicak J, H, Lin N, H, Arnold W, W, Holladay M, M, Williams, P, Arneric S

Publikováno v: The Journal of Pharmacology and Experimental Therapeutics; May 1998, Vol. 285 Issue: 2 p787-94, 8p